What is the recommended management for a patient who presented with fever and leukocytosis, improved after one week of antibiotics and discharge, but now returns one week later with recurrent fever and leukocytosis?

Management of Recurrent Fever and Leukocytosis After Initial Antibiotic Response

For a patient presenting with recurrent fever and leukocytosis one week after discharge from successful antibiotic therapy, you must immediately investigate for persistent/recurrent infection with empiric broad-spectrum antibiotics while simultaneously evaluating for fungal infection and considering non-infectious causes.

Immediate Assessment and Risk Stratification

The recurrence pattern suggests either:

• Inadequate source control of the original infection
• Resistant or unrecognized pathogen
• Fungal superinfection (especially if neutropenic)
• Drug fever from the initial antibiotic course
• Non-infectious inflammatory process

Critical First Steps

Check the neutrophil count immediately. If the patient is neutropenic (ANC <500/μL) or has persistent neutropenia from the initial presentation:

• Add empiric antifungal therapy to the antibacterial regimen, as yeasts and molds are the primary cause of persistent/recurrent fever in neutropenic patients 1
• Use voriconazole (6 mg/kg IV q12h × 2 doses, then 4 mg/kg IV q12h) or lipid formulation amphotericin B (3-5 mg/kg/d) 1
• Fluconazole is an acceptable alternative for initial empiric coverage, but escalate if fever persists 1

For Non-Neutropenic Patients

If neutrophil count is normal or elevated:

1. Obtain blood cultures before restarting antibiotics (at least 2 sets from different sites)

2. Image the original infection site to assess for:

   • Undrained abscess or fluid collection
   • Necrotizing soft tissue infection
   • Septic thrombophlebitis (consider Lemierre's syndrome if pharyngeal source) 2

3. Consider FDG-PET/CT for persistent fever without clear source, as recent evidence shows utility in guiding antimicrobial rationalization 3

Antibiotic Management Algorithm

If Original Infection Site Identified:

Restart broad-spectrum antibiotics immediately - do not wait for culture results:

• Vancomycin PLUS an antipseudomonal agent (cefepime, meropenem, or piperacillin-tazobactam) 1
• This covers MRSA, resistant gram-negatives, and Pseudomonas
• Duration: 7-14 days for most bacterial infections 1

Critical Pitfall - Persistent Leukocytosis

A patient who is afebrile but maintains leukocytosis at antibiotic completion has 33% risk of developing intra-abdominal infection 4. In your case, the patient was discharged with "lower" leukocytes - if not fully normalized, this represents incomplete treatment.

• Patients still febrile at antibiotic discontinuation have 79% risk of post-treatment infection 4
• Of those developing recurrent intra-abdominal infection, only 27% respond to antibiotics alone - most require surgical intervention 4

Surgical Evaluation

Obtain urgent surgical consultation if:

• Intra-abdominal or deep soft tissue source suspected
• Any imaging shows fluid collection or abscess
• Clinical deterioration despite 48-72 hours of appropriate antibiotics

Drainage is essential for source control and may be the reason for initial treatment failure 1.

Duration and Monitoring

• Continue antibiotics for minimum 7-14 days after documented clinical improvement 1
• Do not discontinue antibiotics until:
  • Afebrile for ≥48-72 hours 5
  • Leukocyte count normalizing (not just "lower") 4
  • Clinical stability confirmed
  • Source control achieved if applicable

Special Consideration for Drug Fever

If fever recurs with leukocytosis (or paradoxically, agranulocytosis) and no infectious source is identified after thorough workup, consider piperacillin-tazobactam-induced drug fever if this was the initial antibiotic 6. This typically occurs with prolonged therapy and requires:

• Discontinuation of the offending agent
• Switch to alternative antibiotic class
• Supportive care (G-CSF if agranulocytosis present)

Key Clinical Pearls

• Never assume the same antibiotic will work for recurrent infection - resistance or inadequate source control is likely
• Persistent leukocytosis = incomplete treatment, even if afebrile
• Neutropenic patients with recurrent fever = fungal infection until proven otherwise 1
• Early imaging is critical - don't treat blindly for extended periods 3
• Risk of recurrent infection correlates with absolute neutrophil count and monocyte count at initial treatment cessation 7